159 related articles for article (PubMed ID: 27650910)
1. Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain.
Tong J; Mizrahi R; Houle S; Kish SJ; Boileau I; Nobrega J; Rusjan PM; Wilson AA
J Cereb Blood Flow Metab; 2017 Nov; 37(11):3635-3639. PubMed ID: 27650910
[TBL] [Abstract][Full Text] [Related]
2. Global Portrait of Protein Targets of Metabolites of the Neurotoxic Compound BIA 10-2474.
Huang Z; Ogasawara D; Seneviratne UI; Cognetta AB; Am Ende CW; Nason DM; Lapham K; Litchfield J; Johnson DS; Cravatt BF
ACS Chem Biol; 2019 Feb; 14(2):192-197. PubMed ID: 30702848
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.
Kiss LE; Beliaev A; Ferreira HS; Rosa CP; Bonifácio MJ; Loureiro AI; Pires NM; Palma PN; Soares-da-Silva P
ChemMedChem; 2018 Oct; 13(20):2177-2188. PubMed ID: 30113139
[TBL] [Abstract][Full Text] [Related]
4. [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.
Wilson AA; Garcia A; Parkes J; Houle S; Tong J; Vasdev N
Nucl Med Biol; 2011 Feb; 38(2):247-53. PubMed ID: 21315280
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.
Hicks JW; Parkes J; Sadovski O; Tong J; Houle S; Vasdev N; Wilson AA
Nucl Med Biol; 2013 Aug; 40(6):740-6. PubMed ID: 23731552
[TBL] [Abstract][Full Text] [Related]
6. ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain.
Kiso T; Watabiki T; Sekizawa T
Eur J Pharmacol; 2020 Aug; 881():173194. PubMed ID: 32445705
[TBL] [Abstract][Full Text] [Related]
7. Commentary on BIA 10-2474.
Hayes AW
Regul Toxicol Pharmacol; 2020 Mar; 111():104541. PubMed ID: 31759139
[No Abstract] [Full Text] [Related]
8. Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers.
Rocha JF; Santos A; Gama H; Moser P; Falcão A; Pressman P; Wallace Hayes A; Soares-da-Silva P
Clin Pharmacol Ther; 2022 Feb; 111(2):391-403. PubMed ID: 33998672
[TBL] [Abstract][Full Text] [Related]
9. Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474.
Bonifácio MJ; Sousa F; Aires C; Loureiro AI; Fernandes-Lopes C; Pires NM; Palma PN; Moser P; Soares-da-Silva P
Br J Pharmacol; 2020 May; 177(9):2123-2142. PubMed ID: 31901141
[TBL] [Abstract][Full Text] [Related]
10. Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.
van Esbroeck ACM; Janssen APA; Cognetta AB; Ogasawara D; Shpak G; van der Kroeg M; Kantae V; Baggelaar MP; de Vrij FMS; Deng H; Allarà M; Fezza F; Lin Z; van der Wel T; Soethoudt M; Mock ED; den Dulk H; Baak IL; Florea BI; Hendriks G; De Petrocellis L; Overkleeft HS; Hankemeier T; De Zeeuw CI; Di Marzo V; Maccarrone M; Cravatt BF; Kushner SA; van der Stelt M
Science; 2017 Jun; 356(6342):1084-1087. PubMed ID: 28596366
[TBL] [Abstract][Full Text] [Related]
11. Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB.
Boileau I; Rusjan PM; Williams B; Mansouri E; Mizrahi R; De Luca V; Johnson DS; Wilson AA; Houle S; Kish SJ; Tong J
J Cereb Blood Flow Metab; 2015 Nov; 35(11):1827-35. PubMed ID: 26082009
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.
Chang L; Luo L; Palmer JA; Sutton S; Wilson SJ; Barbier AJ; Breitenbucher JG; Chaplan SR; Webb M
Br J Pharmacol; 2006 May; 148(1):102-13. PubMed ID: 16501580
[TBL] [Abstract][Full Text] [Related]
13. The absence of genotoxicity of a novel fatty acid amide hydrolase inhibitor, BIA 10-2474.
Hayes AW; Hardisty JF; Harris SB; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104556. PubMed ID: 31866344
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preliminary evaluation of a novel positron emission tomography (PET) ligand for imaging fatty acid amide hydrolase (FAAH).
Chen Z; Hou L; Gan J; Cai Q; Ye W; Chen J; Tan Z; Zheng C; Li G; Xu H; Fowler CJ; Liang SH; Wang L
Bioorg Med Chem Lett; 2020 Nov; 30(21):127513. PubMed ID: 32860981
[TBL] [Abstract][Full Text] [Related]
16. Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers.
Postnov A; Schmidt ME; Pemberton DJ; de Hoon J; van Hecken A; van den Boer M; Zannikos P; van der Ark P; Palmer JA; Rassnick S; Celen S; Bormans G; van Laere K
Clin Transl Sci; 2018 Jul; 11(4):397-404. PubMed ID: 29575526
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold.
Wang L; Yui J; Wang Q; Zhang Y; Mori W; Shimoda Y; Fujinaga M; Kumata K; Yamasaki T; Hatori A; Rotstein BH; Collier TL; Ran C; Vasdev N; Zhang MR; Liang SH
ACS Chem Neurosci; 2016 Jan; 7(1):109-18. PubMed ID: 26505525
[TBL] [Abstract][Full Text] [Related]
18. Development of [(11)C]MFTC for PET imaging of fatty acid amide hydrolase in rat and monkey brains.
Kumata K; Yui J; Hatori A; Maeda J; Xie L; Ogawa M; Yamasaki T; Nagai Y; Shimoda Y; Fujinaga M; Kawamura K; Zhang MR
ACS Chem Neurosci; 2015 Feb; 6(2):339-46. PubMed ID: 25398123
[TBL] [Abstract][Full Text] [Related]
19. Development of an In Vivo Method to Estimate Effective Drug Doses and Quantify Fatty Acid Amide Hydrolase in Rodent Brain using Positron Emission Tomography Tracer [
Yamasaki T; Ohya T; Mori W; Zhang Y; Wakizaka H; Nengaki N; Fujinaga M; Kikuchi T; Zhang MR
J Pharmacol Exp Ther; 2020 Jun; 373(3):353-360. PubMed ID: 32241809
[TBL] [Abstract][Full Text] [Related]
20. The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH).
Skaddan MB; Zhang L; Johnson DS; Zhu A; Zasadny KR; Coelho RV; Kuszpit K; Currier G; Fan KH; Beck EM; Chen L; Drozda SE; Balan G; Niphakis M; Cravatt BF; Ahn K; Bocan T; Villalobos A
Nucl Med Biol; 2012 Oct; 39(7):1058-67. PubMed ID: 22571907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
